Are you a new member? Sign up now
Login area
| Sign up
close
ENTYVIO - 108mg - 2
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA33 | BioTech | Vedolizumab - 108mg | 10627 | 56321/1 | ENTYVIO | 108mg | 2 | Injectable solution | SC | Century Pharma SAL | Takeda Austria GmbH | Austria | 86,348,304 L.L | 2.44 | E2 | Takeda Pharma AS | Denmark | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA33 | BioTech | Vedolizumab - 108mg | 10628 | 56221/1 | ENTYVIO | 108mg | 2 | Injectable solution | SC | Century Pharma SAL | Takeda Austria GmbH | Austria | 86,348,304 L.L | 2.44 | E2 | Takeda Pharma AS | Denmark | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024